17-6707069-C-A
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_177550.5(SLC13A5):c.190G>T(p.Val64Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,792 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V64I) has been classified as Uncertain significance.
Frequency
Consequence
NM_177550.5 missense
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 25Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- amelocerebrohypohidrotic syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- pyridoxine-dependent epilepsyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD4 exome  AF:  6.84e-7  AC: 1AN: 1461792Hom.:  0  Cov.: 32 AF XY:  0.00000138  AC XY: 1AN XY: 727188 show subpopulations 
Age Distribution
GnomAD4 genome  
ClinVar
Not reported inComputational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at